Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Lingling Du

Hematology Oncology
1514 Jefferson Highway, 
New Orleans, LA 
On Staff At
Accepting New Patients
Offers Telehealth
Experienced in WT1-Related Wilms Tumor Syndromes
1514 Jefferson Highway, 
New Orleans, LA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lingling Du is a Hematologist Oncology provider in New Orleans, Louisiana. Dr. Du is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Neuroendocrine Tumor, Gastroesophageal Junction Cancer, Familial Colorectal Cancer, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Dr. Du is currently accepting new patients.

Her clinical research consists of co-authoring 22 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Peking Union Medical College/Capital Med, Medical Degree, 2011
Residency
Cleveland Clinic Foundation GME, Internal Medicine, 2014
Specialties
Hematology Oncology
Licenses
Student in an Organized Health Care Education/Training Program in OH
Board Certifications
American Board Of Internal Medicine - Hematology/Oncology
American Board Of Internal Medicine - Internal Medicine
Fellowships
Barnes Jewish Hospital, Hematology/Oncology
Year Completed: 2017
Hospital Affiliations
Ochsner Medical Center Acute
Slidell Memorial Hospital
St Charles Parish Hospital
Ochsner Medical Center-Kenner
Ochsner Medical Center - Baton Rouge
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

The Gayle and Tom Benson Cancer Center
1514 Jefferson Highway, New Orleans, LA 70121
Other Locations
Ochsner Health Center - Kenner
200 W Esplanade Ave, Kenner, LA 70065

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
Enrollment Status: Completed
Publish Date: June 11, 2025
Intervention Type: Drug
Study Drugs: Cisplatin, Gemcitabine, Nab-Paclitaxel
Study Phase: Phase 3
Adjuvant Low Dose Rituximab for Acquired TTP With Severe ADAMTS13 Deficiency
Adjuvant Low Dose Rituximab for Acquired TTP With Severe ADAMTS13 Deficiency
Enrollment Status: Completed
Publish Date: August 17, 2021
Intervention Type: Biological
Study Phase: Phase 2
View 1 Less Clinical Trial

23 Total Publications

Contemporary Clinical Utilization of Radioembolization with Immune Checkpoint Inhibitors as First-Line Treatment in HCC: Real-World Report on Safety and Outcomes.
Contemporary Clinical Utilization of Radioembolization with Immune Checkpoint Inhibitors as First-Line Treatment in HCC: Real-World Report on Safety and Outcomes.
Journal: Cancers
Published: July 22, 2025
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. David N. Oubre
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. David N. Oubre
Hematology Oncology | Hematology | Oncology

Pontchartrain Cancer Center Inc

15799 Professional Plz, 
Hammond, LA 
 (40.1 miles away)
985-419-0025
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Oubre is a Hematologist Oncology specialist and a Hematologist in Hammond, Louisiana. Dr. Oubre is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, Paris-Trousseau Thrombocytopenia, and Bone Marrow Aspiration. Dr. Oubre is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ronald Leblanc
Hematology Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ronald Leblanc
Hematology Oncology

Slidell Regional Cancer Center - A Campus Of Ochsner Medical Center

1120 Robert Blvd, 
Slidell, LA 
 (31.8 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ronald Leblanc is a Hematologist Oncology provider in Slidell, Louisiana. Dr. Leblanc is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Childhood Iron Deficiency Anemia, Paget Disease of the Breast, Familial Colorectal Cancer, and Clear Cell Sarcoma. Dr. Leblanc is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Jodi L. Layton
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Jodi L. Layton
Hematology Oncology | Hematology | Oncology
2000 Canal St, 
New Orleans, LA 
 (3.9 miles away)
504-702-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jodi Layton is a Hematologist Oncology specialist and a Hematologist in New Orleans, Louisiana. Dr. Layton is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Renal Cell Carcinoma (RCC), Wilms Tumor, Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes. Dr. Layton is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Du's expertise for a condition
ConditionClose
    View All 62 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile